SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

04 Feb 2026 Evaluate
The December 2025 quarter revenue stood at Rs. 430.24 millions, up 16.62% as compared to Rs. 368.93 millions during the corresponding quarter last year.A slender decline of -8.87% was recorded to Rs. 59.31  millions from Rs. 65.08 millions in the corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 92.45 millions from 104.03 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 430.24 368.93 16.62 1241.09 1106.45 12.17 1516.92 1419.66 6.85
Other Income 18.15 15.82 14.73 59.51 48.41 22.93 67.21 46.67 44.01
PBIDT 92.45 104.03 -11.13 354.43 343.76 3.10 471.13 377.85 24.69
Interest 1.16 1.10 5.45 3.33 3.41 -2.35 4.53 2.71 67.16
PBDT 91.29 102.93 -11.31 351.10 340.35 3.16 466.60 375.14 24.38
Depreciation 8.33 7.79 6.93 22.99 19.37 18.69 27.28 23.40 16.58
PBT 82.96 95.14 -12.80 328.11 320.98 2.22 439.32 351.74 24.90
TAX 23.65 30.06 -21.32 89.24 85.73 4.09 118.72 91.98 29.07
Deferred Tax -6.35 0.06 -10683.33 -0.76 0.73 -204.11 -2.06 -5.21 -60.46
PAT 59.31 65.08 -8.87 238.87 235.25 1.54 320.60 259.76 23.42
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 21.49 28.20 -23.80 28.56 31.07 -8.08 31.06 26.62 16.69

Jenburkt Pharma Share Price

1052.70 2.30 (0.22%)
21-Apr-2026 12:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.15
Dr. Reddys Lab 1221.00
Cipla 1232.00
Zydus Lifesciences 927.80
Lupin 2322.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×